The world is struggling to contain COVID-19, as variants continue to emerge in countries where the virus is spreading unchecked, killing thousands. Not only could widespread vaccination campaigns help slow the emergence of new variants, they would save countless lives. So why cant countries in the global south access the novel COVID-19 vaccines?
We take a deep dive into the WTO and international patents and we talk about the similarity between the current battle and the prior fight for access to antiretrovirals during the HIV pandemic. We also take a look at what needs to change in order to create a more just medical system, not just in the United States, but around the world.